Maximizing the impact of microphysiological systems with in vitro–in vivo translation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maximizing the impact of microphysiological systems with in vitro–in vivo translation
Authors
Keywords
-
Journal
LAB ON A CHIP
Volume 18, Issue 13, Pages 1831-1837
Publisher
Royal Society of Chemistry (RSC)
Online
2018-06-04
DOI
10.1039/c8lc00039e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
- (2018) Collin D. Edington et al. Scientific Reports
- Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS)
- (2017) Christian Maass et al. Integrative Biology
- A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties
- (2017) A. M. Clark et al. LAB ON A CHIP
- Tissue chips – innovative tools for drug development and disease modeling
- (2017) L. A. Low et al. LAB ON A CHIP
- Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
- (2017) Tomasz Kostrzewski et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies
- (2017) Samad Ahadian et al. Advanced Healthcare Materials
- Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
- (2017) Tongcheng Qian et al. Science Advances
- Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model
- (2017) Sophie Bauer et al. Scientific Reports
- Physiologically based pharmacokinetic modeling in regulatory decision-making at the European Medicines Agency
- (2016) E Luzon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?
- (2016) Robert A. Roth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Development of a microphysiological model of human kidney proximal tubule function
- (2016) Elijah J. Weber et al. KIDNEY INTERNATIONAL
- Matched-Comparative Modeling of Normal and Diseased Human Airway Responses Using a Microengineered Breathing Lung Chip
- (2016) Kambez H. Benam et al. Cell Systems
- Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public–private partnerships
- (2016) Christine A. Livingston et al. Computational and Structural Biotechnology Journal
- The promises of quantitative systems pharmacology modelling for drug development
- (2016) V.R. Knight-Schrijver et al. Computational and Structural Biotechnology Journal
- Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
- (2016) Carlota Oleaga et al. Scientific Reports
- Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA
- (2015) Christian Wagner et al. CLINICAL PHARMACOKINETICS
- Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
- (2015) HM Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling
- (2015) Hasan Erbil Abaci et al. Integrative Biology
- Organs-on-chips at the frontiers of drug discovery
- (2015) Eric W. Esch et al. NATURE REVIEWS DRUG DISCOVERY
- Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
- (2014) S E Wheeler et al. BRITISH JOURNAL OF CANCER
- Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration
- (2014) Christian Wagner et al. CLINICAL PHARMACOKINETICS
- The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach
- (2014) M A Kamal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Using physiologically-based pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure
- (2014) Jong Hwan Sung et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
- (2014) Gang Wang et al. NATURE MEDICINE
- Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development
- (2014) Tarek A. Leil et al. Frontiers in Pharmacology
- Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
- (2014) Jeffrey L. Woodhead et al. Frontiers in Pharmacology
- The Utility of Modeling and Simulation in Drug Development and Regulatory Review
- (2013) Shiew-Mei Huang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Scaling and systems biology for integrating multiple organs-on-a-chip
- (2013) John P. Wikswo et al. LAB ON A CHIP
- Microfabricated mammalian organ systems and their integration into models of whole animals and humans
- (2013) Jong H. Sung et al. LAB ON A CHIP
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI
- (2012) Brett A. Howell et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants
- (2011) Neil Parrott et al. CLINICAL PHARMACOKINETICS
- Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis
- (2011) C Schmitt et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phase II failures: 2008–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development
- (2011) Piet H. van der Graaf et al. PHARMACEUTICAL RESEARCH
- A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
- (2010) Jong Hwan Sung et al. LAB ON A CHIP
- Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity
- (2010) Patrick J. Shaw et al. TOXICOLOGICAL SCIENCES
- A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers
- (2008) Daniel A. Tatosian et al. BIOTECHNOLOGY AND BIOENGINEERING
- Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity
- (2004) Kwanchanok Viravaidya et al. BIOTECHNOLOGY PROGRESS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started